Free Access
ARDS-TRALI
Arthur S. Slutsky MD,
Christopher C. Silliman MD, PhD,
Anneke Brand MD, PhD,
Jonathan P. Wallis MD,
Arthur S. Slutsky MD
Vice-President, Research St. Michael s Hospital Toronto, Ontario, Canada
Search for more papers by this authorChristopher C. Silliman MD, PhD
Bonfils Blood Center University of Colorado School of Medicine Denver, Colorado, USA
Search for more papers by this authorAnneke Brand MD, PhD
Sanquin Blood Bank Southwest Region Leiden University Medical Centre (LUMC) Leiden, The Netherlands
Search for more papers by this authorJonathan P. Wallis MD
Consultant Hematologist Freeman Hospital Newcastle upon Tyne, United Kingdom
Search for more papers by this authorArthur S. Slutsky MD,
Christopher C. Silliman MD, PhD,
Anneke Brand MD, PhD,
Jonathan P. Wallis MD,
Arthur S. Slutsky MD
Vice-President, Research St. Michael s Hospital Toronto, Ontario, Canada
Search for more papers by this authorChristopher C. Silliman MD, PhD
Bonfils Blood Center University of Colorado School of Medicine Denver, Colorado, USA
Search for more papers by this authorAnneke Brand MD, PhD
Sanquin Blood Bank Southwest Region Leiden University Medical Centre (LUMC) Leiden, The Netherlands
Search for more papers by this authorJonathan P. Wallis MD
Consultant Hematologist Freeman Hospital Newcastle upon Tyne, United Kingdom
Search for more papers by this author
References
- 1 Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573–7.
- 2 Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997; 37: 719–26.
- 3 Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454–62.
- 4 Wallis JP. Transfusion-related acute lung injury (TRALI)-under-diagnosed and under-reported. Br J Anaesth 2003; 90: 573–6.
- 5 van Buren NL, Stroncek D. F., Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990; 30: 42–5.
- 6 Yomtovian R, Kline W, Press C, et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet 1984; 1: 244–6.
- 7 Engelfriet C. P., Reesink H. W., Brand A, et al. Transfusion-related acute lung injury (TRALI). Vox Sang 2001; 81: 269–83.
- 8 Webert KE, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev 2003; 17: 252–62.
- 9 Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev 1999; 13: 177–86.
- 10 Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001; 41: 1244–8.
- 11 Roffey P, Thangathurai D, Mikhail M, Riad M, Mogos M. TRALI and massive transfusion. Resuscitation 2003; 58: 121.
- 1 Kopko PM, Holland P. V. Transfusion-related acute lung injury. Br J Haematol 1999; 105: 322–9.
- 2 Wallis J. P., Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion 2003; 43: 1053–9.
- 3 Transfusion Related Acute Lung Injury. Rockville, MD: Food and Drug Administration, Center for biologics Evaluation and research, 2001. Available at: http:www.fd.gov.cberltrtrali101901.htm.
- 4 Serious Hazards of Transfusion Annual Report 2001–2002. Manchester , UK : Serious Hazards of Transfusion Office, Manchester Blood Centre, 2003. Available at: http:www.shot-uk.org.
- 5 Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573–7.
- 6 Andreu G, Morel P, Forestier F, et al. Haemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 2002; 42: 1356–64.
- 7 Kopko PM, Marshall CS, MacKenzie MR, Holland P. V., Popovsky MA. Transfusion related acute lung injury; report of a clinical look-back investigation. JAMA 2002; 287:1968.
- 8 Culliford AT, Thomas S, Spencer FC. Fulminating noncardiogenic pulmonary edema: a newly recognized hazard during cardiac operations. J Thorac Cardiovasc Surg 1980; 80: 868–75.
- 9 Dooren MC, Ouwehand WH, Verhoeven AJ, von dem Borne AE, Kuijpers RW. Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies. Lancet 1998; 352: 1601–2.
- 10 Nouraei SM, Wallis J. P., Bolton D, Hasan A. Management of severe transfusion-related acute lung injury with extracorporeal cardiopulmonary support in a four-year-old child. Br J Anaesth 2003; 91: 292–4.
Citing Literature
